Matches in Wikidata for { <http://www.wikidata.org/entity/Q64377634> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- Q64377634 description "artículu científicu espublizáu en xunetu de 2006" @default.
- Q64377634 description "im Juli 2006 veröffentlichter wissenschaftlicher Artikel" @default.
- Q64377634 description "scientific article published on 01 July 2006" @default.
- Q64377634 description "wetenschappelijk artikel" @default.
- Q64377634 description "наукова стаття, опублікована в липні 2006" @default.
- Q64377634 name "Inhibition of the multidrug-resistant phenotype by targeting YB-1 with a conditionally oncolytic adenovirus: implications for combinatorial treatment regimen with chemotherapeutic agents" @default.
- Q64377634 name "Inhibition of the multidrug-resistant phenotype by targeting YB-1 with a conditionally oncolytic adenovirus: implications for combinatorial treatment regimen with chemotherapeutic agents" @default.
- Q64377634 type Item @default.
- Q64377634 label "Inhibition of the multidrug-resistant phenotype by targeting YB-1 with a conditionally oncolytic adenovirus: implications for combinatorial treatment regimen with chemotherapeutic agents" @default.
- Q64377634 label "Inhibition of the multidrug-resistant phenotype by targeting YB-1 with a conditionally oncolytic adenovirus: implications for combinatorial treatment regimen with chemotherapeutic agents" @default.
- Q64377634 prefLabel "Inhibition of the multidrug-resistant phenotype by targeting YB-1 with a conditionally oncolytic adenovirus: implications for combinatorial treatment regimen with chemotherapeutic agents" @default.
- Q64377634 prefLabel "Inhibition of the multidrug-resistant phenotype by targeting YB-1 with a conditionally oncolytic adenovirus: implications for combinatorial treatment regimen with chemotherapeutic agents" @default.
- Q64377634 P1433 Q64377634-986E5FFB-41A8-477C-81CD-956982561F8C @default.
- Q64377634 P1476 Q64377634-3A1CEAF6-566A-4019-AE9A-423926A94442 @default.
- Q64377634 P2093 Q64377634-03A0F4E1-0826-45F4-9FA0-CB9347C82F22 @default.
- Q64377634 P2093 Q64377634-0C2FB318-56FD-4631-AA13-E0B9E4F987DB @default.
- Q64377634 P2093 Q64377634-25B0CD4B-EEAC-4BA6-9474-C1196F3B7815 @default.
- Q64377634 P2093 Q64377634-42388397-EE92-479A-A9BC-31F9C18BF3C2 @default.
- Q64377634 P2093 Q64377634-55D84910-157F-4CDE-B277-DEC69C90527F @default.
- Q64377634 P2093 Q64377634-706B0861-4DED-4F51-8BE3-22A6CB800D94 @default.
- Q64377634 P2093 Q64377634-8D2FA45B-E1AA-4541-AF3A-A4F3A89142DB @default.
- Q64377634 P2093 Q64377634-91225D2A-5A99-4B3A-BD43-8C659869781E @default.
- Q64377634 P2093 Q64377634-9CB4D191-8E7C-420A-9CCB-ACEBCBE31E70 @default.
- Q64377634 P2093 Q64377634-B529E42E-A446-49B6-B6B5-1AFAAA65F2B8 @default.
- Q64377634 P2093 Q64377634-F0CA7C4D-AAB9-4DD0-9F67-5D808A39DA80 @default.
- Q64377634 P304 Q64377634-1F5BECCF-B8DC-453F-B0F6-49E8385146F8 @default.
- Q64377634 P31 Q64377634-5BA8AA09-FB2A-45CC-ACDE-293ABA9E96A6 @default.
- Q64377634 P356 Q64377634-D956C2DD-B9CE-45DC-B91F-3FAF6133F71A @default.
- Q64377634 P407 Q64377634-8AE0F75A-8740-41E0-9FBB-8003A9ABFE5E @default.
- Q64377634 P433 Q64377634-82C7652B-AE45-4ADB-8E4B-F8D1288F465D @default.
- Q64377634 P478 Q64377634-9A4D9593-61D2-450C-93F5-46D32380F1CC @default.
- Q64377634 P50 Q64377634-926DA7E6-8FD5-42A5-AEDF-EFDA9DC3E7C5 @default.
- Q64377634 P577 Q64377634-53FD3358-4B45-4B7F-B411-4D3031AE921C @default.
- Q64377634 P698 Q64377634-6449541D-D01C-4D20-8AAD-12849B2132AD @default.
- Q64377634 P921 Q64377634-2E0CDD3A-B728-4B16-B585-8E45F15CEC31 @default.
- Q64377634 P921 Q64377634-500E2F5F-652F-4F47-9DA1-8711A8363625 @default.
- Q64377634 P921 Q64377634-7B22C7DD-2FAD-4A42-A3AD-D8317DF6C7F6 @default.
- Q64377634 P921 Q64377634-B4F2606E-5448-44CA-A7B3-D084CD31D6DE @default.
- Q64377634 P921 Q64377634-ED6292A3-914C-4DC8-8552-2C53D4A1A7D0 @default.
- Q64377634 P356 0008-5472.CAN-05-2339 @default.
- Q64377634 P698 16849566 @default.
- Q64377634 P1433 Q326097 @default.
- Q64377634 P1476 "Inhibition of the multidrug-resistant phenotype by targeting YB-1 with a conditionally oncolytic adenovirus: implications for combinatorial treatment regimen with chemotherapeutic agents" @default.
- Q64377634 P2093 "Alexa Bieler" @default.
- Q64377634 P2093 "Alexander Kaszubiak" @default.
- Q64377634 P2093 "Alexandra Bernshausen" @default.
- Q64377634 P2093 "Bernd Gansbacher" @default.
- Q64377634 P2093 "Hermann Lage" @default.
- Q64377634 P2093 "Klaus Mantwill" @default.
- Q64377634 P2093 "Nadia Köhler-Vargas" @default.
- Q64377634 P2093 "Per S Holm" @default.
- Q64377634 P2093 "Rudolf Hartung" @default.
- Q64377634 P2093 "Tanja Dravits" @default.
- Q64377634 P2093 "Uwe Treiber" @default.
- Q64377634 P304 "7195-7202" @default.
- Q64377634 P31 Q13442814 @default.
- Q64377634 P356 "10.1158/0008-5472.CAN-05-2339" @default.
- Q64377634 P407 Q1860 @default.
- Q64377634 P433 "14" @default.
- Q64377634 P478 "66" @default.
- Q64377634 P50 Q60663210 @default.
- Q64377634 P577 "2006-07-01T00:00:00Z" @default.
- Q64377634 P698 "16849566" @default.
- Q64377634 P921 Q104053 @default.
- Q64377634 P921 Q1560099 @default.
- Q64377634 P921 Q193447 @default.
- Q64377634 P921 Q643839 @default.
- Q64377634 P921 Q974135 @default.